Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 2 | +14.9K | 100% | $1.21 | +$18.1K |
Sells | 0 | ||||
Net | +2 | +14.9K | 100% | +$18.1K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
David A. Dodd | President, CEO, Director | $52K | +$15.6K | +42.9% | Aug 12, 2024 |
Kelly T. McKee | Chief Medical Officer | $12.9K | +$2.5K | +24.1% | Aug 12, 2024 |
Mark Reynolds | Cfo | $2.6K | Aug 12, 2024 | ||
Nicole Lemerond | Director | Aug 12, 2024 | |||
Mark Newman | Chief Scientific Officer | Aug 12, 2024 | |||
John N. Spencer Jr | Director | Aug 12, 2024 | |||
Dean Kollintzas | Director | Aug 12, 2024 | |||
T. Mcnally | Director | Aug 12, 2024 | |||
John Sharkey | VP, Business Development | Aug 12, 2024 | |||
Jayne Morgan | Director | Aug 12, 2024 | |||
Randal Chase | Director | Aug 12, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|